U.S. flag

An official website of the United States government

NM_153026.3(PRICKLE1):c.374T>C (p.Val125Ala) AND not specified

Germline classification:
Benign (4 submissions)
Last evaluated:
May 6, 2016
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000118054.24

Allele description [Variation Report for NM_153026.3(PRICKLE1):c.374T>C (p.Val125Ala)]

NM_153026.3(PRICKLE1):c.374T>C (p.Val125Ala)

Gene:
PRICKLE1:prickle planar cell polarity protein 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q12
Genomic location:
Preferred name:
NM_153026.3(PRICKLE1):c.374T>C (p.Val125Ala)
Other names:
p.V125A:GTG>GCG
HGVS:
  • NC_000012.12:g.42469460A>G
  • NG_012965.1:g.125311T>C
  • NM_001144881.2:c.374T>C
  • NM_001144882.2:c.374T>C
  • NM_001144883.2:c.374T>C
  • NM_153026.3:c.374T>CMANE SELECT
  • NP_001138353.1:p.Val125Ala
  • NP_001138354.1:p.Val125Ala
  • NP_001138355.1:p.Val125Ala
  • NP_694571.2:p.Val125Ala
  • NC_000012.11:g.42863262A>G
  • NM_153026.2:c.374T>C
Protein change:
V125A
Links:
dbSNP: rs34837068
NCBI 1000 Genomes Browser:
rs34837068
Molecular consequence:
  • NM_001144881.2:c.374T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144882.2:c.374T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144883.2:c.374T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153026.3:c.374T>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000152383Genetic Services Laboratory, University of Chicago
no assertion criteria provided
Likely benigngermlineclinical testing

SCV000171179GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Benign
(Apr 8, 2014)
germlineclinical testing

Citation Link,

SCV000203341Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Benign
(Feb 28, 2014)
germlineclinical testing

Citation Link,

SCV000846552Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Benign
(May 6, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown1not providednot providednot providednot providedclinical testing

Details of each submission

From Genetic Services Laboratory, University of Chicago, SCV000152383.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV000171179.12

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Eurofins Ntd Llc (ga), SCV000203341.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

From Ambry Genetics, SCV000846552.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024